http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012211451-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42d08d60f05a67f5de3ec62deb54b6ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3662ce5995dada5ea3d9873552592af0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 2012-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_151cd91d5a09feffe5135431de2b791c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d36245121ae868b81a1e760176c2890a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1db0283dc75d540fd0d51194261e584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f582f604fee42cb792aa69f66b0f350
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66f34ace6de4eb2997af1e6c0dd68aa1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19d27b5ce9e25aa18449c60f4ec63b29
publicationDate 2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2012211451-A1
titleOfInvention High potency recombinant antibodies and method for producing them
abstract HIGH POTENCY RECOMBINANT ANTIBODIES AND METHOD FOR PRODUCING THEM Abstract High potency antibodies, including immunologically active fragments thereof, s having high kinetic association rate constants and optional high affinities are disclosed, along with methods for producing such antibodies. The high potency antibodies disclosed herein are of either the neutralizing or non-neutralizing type and have specificity for antigens displayed by microorganisms, especially viruses, as well as antigenic sites present on cancer cells and on various types of toxins, and the products of toxins. 1o Processes for production high potency neutralizing antibodies and increasing the potency of already existing neutralizing antibodies are also described. Methods of using said antibodies in the prevention and/or treatment of diseases, especially diseases induced or caused by viruses, are disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11161891-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017100540-A2
priorityDate 2000-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00784
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28712
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00791
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28713
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35002
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71961
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11489
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81497
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9N2D4
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1977402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02701
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID42415
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97398
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00792
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00793
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487110
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY7
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1977402
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID42415
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123648
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27821
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536506
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051

Total number of triples: 77.